OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

REGISTERED COMPANY NUMBER: (England and Wales) REGISTERED CHARITY NUMBER: 1199493

Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 March 2024

for

Thalassemia Relief CIO

Lindley Adams Limited Chartered Accountants 28 Prescott Street Halifax West Yorkshire HX1 2LG

Thalassemia Relief CIO

Contents of the Financial Statements for the Year Ended 31 March 2024

Page
Reference and Administrative Details 1
Report of the Trustees 2 to 4
Statement of Financial Activities 5
Balance Sheet 6
Notes to the Financial Statements 7 to 9
Detailed Statement of Financial Activities 10

Thalassemia Relief CIO

Reference and Administrative Details for the Year Ended 31 March 2024

TRUSTEES A Khan Chair Ms S Kousar Mrs R L Khan COMPANY SECRETARY REGISTERED OFFICE 19 Overton Drive Bradford West Yorkshire BD6 3NE REGISTERED COMPANY NUMBER (England and Wales) REGISTERED CHARITY NUMBER 1199493 ACCOUNTANTS Lindley Adams Limited Chartered Accountants 28 Prescott Street Halifax West Yorkshire HX1 2LG BANKERS Unity Trust Bank PO Box 7193 Planetary Road Willenhall WV1 9DG

Page 1

Thalassemia Relief CIO

Report of the Trustees for the Year Ended 31 March 2024

The trustees present their report and financial statements for the period ended 31st March 2024 The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in th UK and Republic of Ireland (FRS 102) (effective 1 January 2019)

OBJECTIVES AND ACTIVITIES

Objectives and aims

The objects of the CIO are the relief of sickness and the preservation of health of those suffering from thalassemia who reside in Pakistan.

Significant activities

During the period the charity has raised money from public donations.

The monies raised have been used to support the charity's objects in Pakistan.

Public benefit

The charity has referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the aims and objectives and in planning the charity's future activities. In particular the trustees consider how planned activities will contribute to the aims and objectives they have set.

Grantmaking

The charity has established its grant making policy to achieve its objects for the public benefit to improve the health of those suffering from thalassemia in Pakistan.

Volunteers

The charity was grateful for the support of 10 volunteers during the period.

ACHIEVEMENT AND PERFORMANCE

Charitable activities

During the year £15100 ( 2023 £8760) grants were made for the treatment of individuals suffering from thalassemia in Pakistan.

Fundraising activities

During the period the charity has raised money from the public by street collections, by having collection boxes in shops,hotels etc. and by direct donations.

FINANCIAL REVIEW

Financial position

During the year the charity has raised £23011 ( 2023 £17451 ) from its fundraising activities. Costs relating to the raising of funds amounted to 5115( 2023 £6129), donations made amounted to £15100 ( 2023 £8760) and other costs amounted to £1772 ( 2023 £3434 which included the costs of setting up the CIO). Overall there was a surplus of £1024 for the year ( 2023 deficit of £872 ). Reserves and free reserves at 31st March 2024 were £152 ( 2023 negative £872.).

Principal funding sources

The principal funding sources were collections from the public.

Reserves policy

The trustees wish to establish a level of reserves (that is those funds that are freely available) that is adequate to enable the charity to operate and meet its objectives and enable the charity to continue as a going concern

Going concern

The trustees have considered the position regarding going concern and have looked at forecasts and are satisfied that,despite only having small reserves at the year end, that the charity will have adequate resources to continue to operate for the foreseeable future.In the short term any deficiencies will be made good by the trustees and donations abroad will be restricted unless sufficient funds are available.For these reasons the trustees continue to adopt the going concern basis for preparing these financial statements.

FUTURE PLANS

The trustees intend to continue collecting donations and fundraising in order to support its charitable projects in Pakistan.

Page 2

Thalassemia Relief CIO

Report of the Trustees for the Year Ended 31 March 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charity is a Charitable Incorporated Organization (CIO) governed according to its constitution dated on 27th June 2022 .The CIO was recognized as a charity on 29th June 2022 and took over the work of the previously unincorporated association at that date.

The Charity's first accounts covered the period from 18th July 2022 to 31st March 2023

The CIO is an independent charity and not part of any "umbrella" body and is registered in England.

In the event of the CIO being wound up, the members have no liability to contribute to its assets and no personal responsibility for settling its debts and liabilities.

Recruitment and appointment of new trustees

There must be a minimum of three charity trustees. There is no maximum number of trustees.

Apart from the first charity trustees, every trustee must be appointed for a term of three years by a resolution passed at a properly convened meeting of the charity trustees.

In selecting individuals for appointment as charity trustees , the charity trustees must have regard to the skills, knowledge and experience needed for the effective administration of the CIO.

Organisational structure

The trustees manage the affairs of the CIO and make all decisions regarding strategic matters, fundraising and all expenditure.

Induction and training of new trustees

New trustees are supplied with a copy of the constitution and the latest Trustees Annual Report and Accounts and information detailing their role as a trustee and their responsibilities.Training sessions will be given to new trustees to familiarize themselves with the charity and their obligations.

Related parties

The only related parties are the trustees and Mr. B Hussain, a volunteer in Pakistan who is the brother in law of Mr. A Khan (trustee) .None of the related parties are remunerated or receive any benefits in kind.

Risk management

The trustees have a duty to identify and review the risks to which the charity is exposed and to establish systems to mitigate those risks and to provide reasonable assurance against fraud and error.

Internal risks are minimised by the implementation of procedures for the authorisation of all transactions and projects and to ensure compliance with legislation.

External risks relate largely to funding as a result of the economic climate resulting in difficulties in the charity supporting its projects. These risks are minimised as the charity will not commit to funding projects unless sufficient resources are in place and will also look to diversify funding as required.

The procedures are periodically reviewed to ensure they still meet the needs of the charity.

COMMENCEMENT OF ACTIVITIES

The charity is a Charitable Incorporated Organization (CIO) governed according to its constitution dated on 27th June 2022 .The CIO was recognized as a charity on 29th June 2022 and took over the work of the previously unincorporated association at that date.

The Charity's first accounts covered the period from 18th July 2022 to 31st March 2023

STATEMENT OF TRUSTEES' RESPONSIBILITIES

The trustees (who are also the directors of Thalassemia Relief CIO for the purposes of company law) are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the trustees are required to

Page 3

Thalassemia Relief CIO

Report of the Trustees for the Year Ended 31 March 2024

STATEMENT OF TRUSTEES' RESPONSIBILITIES - continued

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the board of trustees on 10 January 2025 and signed on its behalf by:

A Khan - Trustee

Page 4

Thalassemia Relief CIO

Statement of Financial Activities for the Year Ended 31 March 2024

Period
29.6.22
Year Ended to
31.3.24 31.3.23
Unrestricted Total
fund funds
Notes £ £
INCOME AND ENDOWMENTS FROM
Donations and legacies 23,011 17,451
EXPENDITURE ON
Raising funds 5,115 6,129
Charitable activities
Charitable activities 15,625 9,010
Other 1,247 3,184
Total 21,987 18,323
NET INCOME/(EXPENDITURE) 1,024 (872)
RECONCILIATION OF FUNDS
Total funds brought forward (872) -
TOTAL FUNDS CARRIED FORWARD 152 (872)
CONTINUING OPERATIONS

All income and expenditure has arisen from continuing activities.

The notes form part of these financial statements

Page 5

Thalassemia Relief CIO

Balance Sheet 31 March 2024

31.3.24 31.3.23
Unrestricted Total
fund funds
Notes £ £
CURRENT ASSETS
Cash at bank 2,112 876
CREDITORS
Amounts falling due within one year 4 (1,960) (1,748)
NET CURRENT ASSETS/(LIABILITIES) 152 (872)
TOTAL ASSETS LESS CURRENT LIABILITIES 152 (872)
NET ASSETS/(LIABILITIES) 152 (872)
FUNDS 5
Unrestricted funds 152 (872)
TOTAL FUNDS 152 (872)

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 10 January 2025 and were signed on its behalf by:

A Khan - Trustee

The notes form part of these financial statements

Page 6

Thalassemia Relief CIO

Notes to the Financial Statements for the Year Ended 31 March 2024

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. At present the CIO has no restricted funds.

Financial instruments

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments.Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Going Concern

These accounts have been prepared on the going concern basis.

2. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2024 nor for the period ended 31 March 2023.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2024 nor for the period ended 31 March 2023.

continued...

Page 7

Thalassemia Relief CIO

Notes to the Financial Statements - continued for the Year Ended 31 March 2024

3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies 17,451
EXPENDITURE ON
Raising funds 6,129
Charitable activities
Charitable activities 9,010
Other 3,184
Total 18,323
NET INCOME/(EXPENDITURE) (872)
TOTAL FUNDS CARRIED FORWARD (872)
4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£ £
Trade creditors 820 308
Accrued expenses 1,140 1,440
1,960 1,748
5. MOVEMENT IN FUNDS
Net
movement At
At 1.4.23 in funds 31.3.24
£ £ £
Unrestricted funds
General fund (872) 1,024 152
TOTAL FUNDS (872) 1,024 152
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 23,011 (21,987) 1,024
TOTAL FUNDS 23,011 (21,987) 1,024

continued...

Page 8

Thalassemia Relief CIO

Notes to the Financial Statements - continued for the Year Ended 31 March 2024

5. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Net
movement At
in funds 31.3.23
£ £
Unrestricted funds
General fund (872) (872)
TOTAL FUNDS (872) (872)
Comparative net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 17,451 (18,323) (872)
TOTAL FUNDS 17,451 (18,323) (872)

6. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2024.

Page 9

Thalassemia Relief CIO

Detailed Statement of Financial Activities for the Year Ended 31 March 2024

Period
29.6.22
Year Ended to
31.3.24 31.3.23
£ £
INCOME AND ENDOWMENTS
Donations and legacies
Donations 23,011 17,451
Total incoming resources 23,011 17,451
EXPENDITURE
Raising donations and legacies
Advertising 750 -
Motor and travel 2,124 2,903
Collection boxes and badges 1,905 2,818
Donation transfer costs 336 408
5,115 6,129
Charitable activities
Sundries 525 250
Grants to individuals 15,100 8,760
15,625 9,010
Support costs
Finance
Interest charges 145 156
Bank charges 82 80
227 236
Governance costs
Accountancy and legal fees 1,020 2,948
Total resources expended 21,987 18,323
Net income/(expenditure) 1,024 (872)

This page does not form part of the statutory financial statements

Page 10